Global Cholesterol Screening

Cholesterol Screening Comprehensive Study by Type (Product (Test Kits, Testing Strips, Devices), Services), Application (Clinics, Hospitals, Ambulatory Centers, Homecare, Diagnostic Centers), Cholesterol Tests (Total Cholesterol Test, HDL Cholesterol Test, LDL Cholesterol Test, Triglycerides/VLDL Cholesterol Test), Test Type (Non-Invasive, Invasive) Players and Region - Global Market Outlook to 2030

Cholesterol Screening Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 8.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Cholesterol Screening
Cholesterol is a waxy, fat-like substance that is found in all cells in our body. If there is too much cholesterol present in the blood, it can further combine with other substances in the blood thus forming plaque that adheres to the walls of the arteries. A full cholesterol test is also known as a lipid panel or lipid profile. A full cholesterol test measures four types of lipids, or fats, in the blood, total cholesterol is therefore the total amount of cholesterol present in the blood. Low-density lipoprotein (LDL) cholesterol is generally known to be as bad cholesterol. A high amount of bad cholesterol increases your risk of heart attack, stroke, and atherosclerosis. Cholesterol screening services enable the early detection of problems related to high cholesterol, avoid complications, and increase patient survival. According to the population department of the Ministry of Economic and Social Affairs, the world population aged 60 and over was around 11.7% in 2013 and is expected to increase further to 21.1% by 2050. According to data that was released by the United Health Foundation in 2017, around 12.5% of people who were aged 60 and over had high levels of total cholesterol. Such a high prevalence is hence expected to drive market growth in the near future.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR8.1%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Cholesterol Screening market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

ACM Medical Laboratory (United States), Clinical Reference Laboratory (CRL) (United States), Unilabs (Switzerland), Laboratory Corporation of America (LabCorp) (United States), Eurofins Scientific (Luxembourg), Quest Diagnostics Incorporated (United States), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (United States) and Fresenius Medical Care Holdings, Inc. (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Spectra Laboratories Inc. (United States) and Adicon Clinical Laboratory (China).

Segmentation Overview
AMA Research has segmented the market of Global Cholesterol Screening market by Type (Product [Test Kits, Testing Strips, Devices] and Services), Application (Clinics, Hospitals, Ambulatory Centers, Homecare and Diagnostic Centers) and Region.



On the basis of geography, the market of Cholesterol Screening has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Cholesterol Tests, the sub-segment i.e. Total Cholesterol Test will boost the Cholesterol Screening market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Test Type, the sub-segment i.e. Non-Invasive will boost the Cholesterol Screening market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Number of Testing Facilities in the Developing Regions and Rise In Public Awareness about the Cardiovascular Disease, Its Causes, Treatment, and Prevention

Market Growth Drivers:
Increase in Incidence of Cardiovascular Diseases and Obesity, A Rapid Growth in Sedentary Lifestyle, Increasing Awareness Regarding Routine Screening of Cholesterol Level and Rise in Geriatric Population Offering a Large Patient Pool

Challenges:
The Advent of Noninvasive Cholesterol Testing Approaches

Restraints:
Swift Growth in Self-Testing Devices

Opportunities:
Government Initiatives for Better Healthcare Services, Increase in Healthcare Expenditure and Government Initiatives to Improve Quality of Testing

Market Leaders and their expansionary development strategies
In September 2023, The ACC, through a strategic collaboration with Amgen and Esperion, is launching a new quality improvement campaign, "Driving Urgency in LDL Screening," to increase the rate of diagnostic LDL screening in patients without a prior cardiac event as well as those with known cardiovascular disease to help clinicians identify those who need treatment in accordance with medical guidelines.
In November 2023, Amgen announced new data reinforcing the safety and efficacy of Repatha® (evolocumab) from the FOURIER Open Label Extension (OLE) [FOURIER-OLE] trial at the American Heart Association (AHA) Scientific Sessions 2023 in Philadelphia. These presentations will focus on the reduction of a known cardiovascular disease (CVD) risk factor, LDL "bad" cholesterol (LDL-C).


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Cholesterol Screening, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Product [Test Kits, Testing Strips, Devices]
  • Services
By Application
  • Clinics
  • Hospitals
  • Ambulatory Centers
  • Homecare
  • Diagnostic Centers
By Cholesterol Tests
  • Total Cholesterol Test
  • HDL Cholesterol Test
  • LDL Cholesterol Test
  • Triglycerides/VLDL Cholesterol Test

By Test Type
  • Non-Invasive
  • Invasive

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Incidence of Cardiovascular Diseases and Obesity
      • 3.2.2. A Rapid Growth in Sedentary Lifestyle
      • 3.2.3. Increasing Awareness Regarding Routine Screening of Cholesterol Level
      • 3.2.4. Rise in Geriatric Population Offering a Large Patient Pool
    • 3.3. Market Challenges
      • 3.3.1. The Advent of Noninvasive Cholesterol Testing Approaches
    • 3.4. Market Trends
      • 3.4.1. Growing Number of Testing Facilities in the Developing Regions
      • 3.4.2. Rise In Public Awareness about the Cardiovascular Disease, Its Causes, Treatment, and Prevention
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cholesterol Screening, by Type, Application, Cholesterol Tests, Test Type and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Cholesterol Screening (Value)
      • 5.2.1. Global Cholesterol Screening by: Type (Value)
        • 5.2.1.1. Product [Test Kits, Testing Strips, Devices]
        • 5.2.1.2. Services
      • 5.2.2. Global Cholesterol Screening by: Application (Value)
        • 5.2.2.1. Clinics
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Ambulatory Centers
        • 5.2.2.4. Homecare
        • 5.2.2.5. Diagnostic Centers
      • 5.2.3. Global Cholesterol Screening by: Cholesterol Tests (Value)
        • 5.2.3.1. Total Cholesterol Test
        • 5.2.3.2. HDL Cholesterol Test
        • 5.2.3.3. LDL Cholesterol Test
        • 5.2.3.4. Triglycerides/VLDL Cholesterol Test
      • 5.2.4. Global Cholesterol Screening by: Test Type (Value)
        • 5.2.4.1. Non-Invasive
        • 5.2.4.2. Invasive
      • 5.2.5. Global Cholesterol Screening Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Cholesterol Screening (Price)
      • 5.3.1. Global Cholesterol Screening by: Type (Price)
  • 6. Cholesterol Screening: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. ACM Medical Laboratory (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Clinical Reference Laboratory (CRL) (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Unilabs (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Laboratory Corporation of America (LabCorp) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Eurofins Scientific (Luxembourg)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Quest Diagnostics Incorporated (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. SYNLAB International GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Reference Laboratories Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Fresenius Medical Care Holdings, Inc. (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Cholesterol Screening Sale, by Type, Application, Cholesterol Tests, Test Type and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Cholesterol Screening (Value)
      • 7.2.1. Global Cholesterol Screening by: Type (Value)
        • 7.2.1.1. Product [Test Kits, Testing Strips, Devices]
        • 7.2.1.2. Services
      • 7.2.2. Global Cholesterol Screening by: Application (Value)
        • 7.2.2.1. Clinics
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Ambulatory Centers
        • 7.2.2.4. Homecare
        • 7.2.2.5. Diagnostic Centers
      • 7.2.3. Global Cholesterol Screening by: Cholesterol Tests (Value)
        • 7.2.3.1. Total Cholesterol Test
        • 7.2.3.2. HDL Cholesterol Test
        • 7.2.3.3. LDL Cholesterol Test
        • 7.2.3.4. Triglycerides/VLDL Cholesterol Test
      • 7.2.4. Global Cholesterol Screening by: Test Type (Value)
        • 7.2.4.1. Non-Invasive
        • 7.2.4.2. Invasive
      • 7.2.5. Global Cholesterol Screening Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Cholesterol Screening (Price)
      • 7.3.1. Global Cholesterol Screening by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cholesterol Screening: by Type(USD Million)
  • Table 2. Cholesterol Screening Product [Test Kits, Testing Strips, Devices] , by Region USD Million (2018-2023)
  • Table 3. Cholesterol Screening Services , by Region USD Million (2018-2023)
  • Table 4. Cholesterol Screening: by Application(USD Million)
  • Table 5. Cholesterol Screening Clinics , by Region USD Million (2018-2023)
  • Table 6. Cholesterol Screening Hospitals , by Region USD Million (2018-2023)
  • Table 7. Cholesterol Screening Ambulatory Centers , by Region USD Million (2018-2023)
  • Table 8. Cholesterol Screening Homecare , by Region USD Million (2018-2023)
  • Table 9. Cholesterol Screening Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 10. Cholesterol Screening: by Cholesterol Tests(USD Million)
  • Table 11. Cholesterol Screening Total Cholesterol Test , by Region USD Million (2018-2023)
  • Table 12. Cholesterol Screening HDL Cholesterol Test , by Region USD Million (2018-2023)
  • Table 13. Cholesterol Screening LDL Cholesterol Test , by Region USD Million (2018-2023)
  • Table 14. Cholesterol Screening Triglycerides/VLDL Cholesterol Test , by Region USD Million (2018-2023)
  • Table 15. Cholesterol Screening: by Test Type(USD Million)
  • Table 16. Cholesterol Screening Non-Invasive , by Region USD Million (2018-2023)
  • Table 17. Cholesterol Screening Invasive , by Region USD Million (2018-2023)
  • Table 18. South America Cholesterol Screening, by Country USD Million (2018-2023)
  • Table 19. South America Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 20. South America Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 21. South America Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 22. South America Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 23. Brazil Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 24. Brazil Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 25. Brazil Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 26. Brazil Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 27. Argentina Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 28. Argentina Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 29. Argentina Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 30. Argentina Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 31. Rest of South America Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 32. Rest of South America Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 33. Rest of South America Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 34. Rest of South America Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 35. Asia Pacific Cholesterol Screening, by Country USD Million (2018-2023)
  • Table 36. Asia Pacific Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 37. Asia Pacific Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 38. Asia Pacific Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 39. Asia Pacific Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 40. China Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 41. China Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 42. China Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 43. China Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 44. Japan Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 45. Japan Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 46. Japan Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 47. Japan Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 48. India Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 49. India Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 50. India Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 51. India Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 52. South Korea Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 53. South Korea Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 54. South Korea Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 55. South Korea Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 56. Taiwan Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 57. Taiwan Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 58. Taiwan Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 59. Taiwan Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 60. Australia Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 61. Australia Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 62. Australia Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 63. Australia Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 68. Europe Cholesterol Screening, by Country USD Million (2018-2023)
  • Table 69. Europe Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 70. Europe Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 71. Europe Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 72. Europe Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 73. Germany Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 74. Germany Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 75. Germany Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 76. Germany Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 77. France Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 78. France Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 79. France Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 80. France Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 81. Italy Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 82. Italy Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 83. Italy Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 84. Italy Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 85. United Kingdom Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 86. United Kingdom Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 87. United Kingdom Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 88. United Kingdom Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 89. Netherlands Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 90. Netherlands Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 91. Netherlands Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 92. Netherlands Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 93. Rest of Europe Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 94. Rest of Europe Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 95. Rest of Europe Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 96. Rest of Europe Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 97. MEA Cholesterol Screening, by Country USD Million (2018-2023)
  • Table 98. MEA Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 99. MEA Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 100. MEA Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 101. MEA Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 102. Middle East Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 103. Middle East Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 104. Middle East Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 105. Middle East Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 106. Africa Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 107. Africa Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 108. Africa Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 109. Africa Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 110. North America Cholesterol Screening, by Country USD Million (2018-2023)
  • Table 111. North America Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 112. North America Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 113. North America Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 114. North America Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 115. United States Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 116. United States Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 117. United States Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 118. United States Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 119. Canada Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 120. Canada Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 121. Canada Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 122. Canada Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 123. Mexico Cholesterol Screening, by Type USD Million (2018-2023)
  • Table 124. Mexico Cholesterol Screening, by Application USD Million (2018-2023)
  • Table 125. Mexico Cholesterol Screening, by Cholesterol Tests USD Million (2018-2023)
  • Table 126. Mexico Cholesterol Screening, by Test Type USD Million (2018-2023)
  • Table 127. Cholesterol Screening: by Type(USD/Units)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Cholesterol Screening: by Type(USD Million)
  • Table 138. Cholesterol Screening Product [Test Kits, Testing Strips, Devices] , by Region USD Million (2025-2030)
  • Table 139. Cholesterol Screening Services , by Region USD Million (2025-2030)
  • Table 140. Cholesterol Screening: by Application(USD Million)
  • Table 141. Cholesterol Screening Clinics , by Region USD Million (2025-2030)
  • Table 142. Cholesterol Screening Hospitals , by Region USD Million (2025-2030)
  • Table 143. Cholesterol Screening Ambulatory Centers , by Region USD Million (2025-2030)
  • Table 144. Cholesterol Screening Homecare , by Region USD Million (2025-2030)
  • Table 145. Cholesterol Screening Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 146. Cholesterol Screening: by Cholesterol Tests(USD Million)
  • Table 147. Cholesterol Screening Total Cholesterol Test , by Region USD Million (2025-2030)
  • Table 148. Cholesterol Screening HDL Cholesterol Test , by Region USD Million (2025-2030)
  • Table 149. Cholesterol Screening LDL Cholesterol Test , by Region USD Million (2025-2030)
  • Table 150. Cholesterol Screening Triglycerides/VLDL Cholesterol Test , by Region USD Million (2025-2030)
  • Table 151. Cholesterol Screening: by Test Type(USD Million)
  • Table 152. Cholesterol Screening Non-Invasive , by Region USD Million (2025-2030)
  • Table 153. Cholesterol Screening Invasive , by Region USD Million (2025-2030)
  • Table 154. South America Cholesterol Screening, by Country USD Million (2025-2030)
  • Table 155. South America Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 156. South America Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 157. South America Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 158. South America Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 159. Brazil Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 160. Brazil Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 161. Brazil Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 162. Brazil Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 163. Argentina Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 164. Argentina Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 165. Argentina Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 166. Argentina Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 167. Rest of South America Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 168. Rest of South America Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 169. Rest of South America Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 170. Rest of South America Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 171. Asia Pacific Cholesterol Screening, by Country USD Million (2025-2030)
  • Table 172. Asia Pacific Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 173. Asia Pacific Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 174. Asia Pacific Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 175. Asia Pacific Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 176. China Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 177. China Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 178. China Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 179. China Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 180. Japan Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 181. Japan Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 182. Japan Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 183. Japan Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 184. India Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 185. India Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 186. India Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 187. India Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 188. South Korea Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 189. South Korea Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 190. South Korea Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 191. South Korea Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 192. Taiwan Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 193. Taiwan Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 194. Taiwan Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 195. Taiwan Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 196. Australia Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 197. Australia Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 198. Australia Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 199. Australia Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 200. Rest of Asia-Pacific Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 201. Rest of Asia-Pacific Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 202. Rest of Asia-Pacific Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 203. Rest of Asia-Pacific Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 204. Europe Cholesterol Screening, by Country USD Million (2025-2030)
  • Table 205. Europe Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 206. Europe Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 207. Europe Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 208. Europe Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 209. Germany Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 210. Germany Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 211. Germany Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 212. Germany Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 213. France Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 214. France Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 215. France Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 216. France Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 217. Italy Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 218. Italy Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 219. Italy Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 220. Italy Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 221. United Kingdom Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 222. United Kingdom Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 223. United Kingdom Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 224. United Kingdom Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 225. Netherlands Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 226. Netherlands Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 227. Netherlands Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 228. Netherlands Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 229. Rest of Europe Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 230. Rest of Europe Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 231. Rest of Europe Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 232. Rest of Europe Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 233. MEA Cholesterol Screening, by Country USD Million (2025-2030)
  • Table 234. MEA Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 235. MEA Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 236. MEA Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 237. MEA Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 238. Middle East Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 239. Middle East Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 240. Middle East Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 241. Middle East Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 242. Africa Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 243. Africa Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 244. Africa Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 245. Africa Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 246. North America Cholesterol Screening, by Country USD Million (2025-2030)
  • Table 247. North America Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 248. North America Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 249. North America Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 250. North America Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 251. United States Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 252. United States Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 253. United States Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 254. United States Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 255. Canada Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 256. Canada Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 257. Canada Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 258. Canada Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 259. Mexico Cholesterol Screening, by Type USD Million (2025-2030)
  • Table 260. Mexico Cholesterol Screening, by Application USD Million (2025-2030)
  • Table 261. Mexico Cholesterol Screening, by Cholesterol Tests USD Million (2025-2030)
  • Table 262. Mexico Cholesterol Screening, by Test Type USD Million (2025-2030)
  • Table 263. Cholesterol Screening: by Type(USD/Units)
  • Table 264. Research Programs/Design for This Report
  • Table 265. Key Data Information from Secondary Sources
  • Table 266. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cholesterol Screening: by Type USD Million (2018-2023)
  • Figure 5. Global Cholesterol Screening: by Application USD Million (2018-2023)
  • Figure 6. Global Cholesterol Screening: by Cholesterol Tests USD Million (2018-2023)
  • Figure 7. Global Cholesterol Screening: by Test Type USD Million (2018-2023)
  • Figure 8. South America Cholesterol Screening Share (%), by Country
  • Figure 9. Asia Pacific Cholesterol Screening Share (%), by Country
  • Figure 10. Europe Cholesterol Screening Share (%), by Country
  • Figure 11. MEA Cholesterol Screening Share (%), by Country
  • Figure 12. North America Cholesterol Screening Share (%), by Country
  • Figure 13. Global Cholesterol Screening: by Type USD/Units (2018-2023)
  • Figure 14. Global Cholesterol Screening share by Players 2023 (%)
  • Figure 15. Global Cholesterol Screening share by Players (Top 3) 2023(%)
  • Figure 16. Global Cholesterol Screening share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. ACM Medical Laboratory (United States) Revenue, Net Income and Gross profit
  • Figure 19. ACM Medical Laboratory (United States) Revenue: by Geography 2023
  • Figure 20. Clinical Reference Laboratory (CRL) (United States) Revenue, Net Income and Gross profit
  • Figure 21. Clinical Reference Laboratory (CRL) (United States) Revenue: by Geography 2023
  • Figure 22. Unilabs (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Unilabs (Switzerland) Revenue: by Geography 2023
  • Figure 24. Laboratory Corporation of America (LabCorp) (United States) Revenue, Net Income and Gross profit
  • Figure 25. Laboratory Corporation of America (LabCorp) (United States) Revenue: by Geography 2023
  • Figure 26. Eurofins Scientific (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 27. Eurofins Scientific (Luxembourg) Revenue: by Geography 2023
  • Figure 28. Quest Diagnostics Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 29. Quest Diagnostics Incorporated (United States) Revenue: by Geography 2023
  • Figure 30. SYNLAB International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 31. SYNLAB International GmbH (Germany) Revenue: by Geography 2023
  • Figure 32. Bio-Reference Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Bio-Reference Laboratories Inc. (United States) Revenue: by Geography 2023
  • Figure 34. Fresenius Medical Care Holdings, Inc. (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Fresenius Medical Care Holdings, Inc. (Germany) Revenue: by Geography 2023
  • Figure 36. Global Cholesterol Screening: by Type USD Million (2025-2030)
  • Figure 37. Global Cholesterol Screening: by Application USD Million (2025-2030)
  • Figure 38. Global Cholesterol Screening: by Cholesterol Tests USD Million (2025-2030)
  • Figure 39. Global Cholesterol Screening: by Test Type USD Million (2025-2030)
  • Figure 40. South America Cholesterol Screening Share (%), by Country
  • Figure 41. Asia Pacific Cholesterol Screening Share (%), by Country
  • Figure 42. Europe Cholesterol Screening Share (%), by Country
  • Figure 43. MEA Cholesterol Screening Share (%), by Country
  • Figure 44. North America Cholesterol Screening Share (%), by Country
  • Figure 45. Global Cholesterol Screening: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • ACM Medical Laboratory (United States)
  • Clinical Reference Laboratory (CRL) (United States)
  • Unilabs (Switzerland)
  • Laboratory Corporation of America (LabCorp) (United States)
  • Eurofins Scientific (Luxembourg)
  • Quest Diagnostics Incorporated (United States)
  • SYNLAB International GmbH (Germany)
  • Bio-Reference Laboratories Inc. (United States)
  • Fresenius Medical Care Holdings, Inc. (Germany)
Additional players considered in the study are as follows:
Spectra Laboratories Inc. (United States) , Adicon Clinical Laboratory (China)
Select User Access Type

Key Highlights of Report


Apr 2024 203 Pages 64 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cholesterol Screening Quantitative research analysis
Global Cholesterol Screening Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as ACM Medical Laboratory (United States), Clinical Reference Laboratory (CRL) (United States), Unilabs (Switzerland), Laboratory Corporation of America (LabCorp) (United States), Eurofins Scientific (Luxembourg), Quest Diagnostics Incorporated (United States), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (United States) and Fresenius Medical Care Holdings, Inc. (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Number of Testing Facilities in the Developing Regions " is seen as one of major influencing trends for Cholesterol Screening Market during projected period 2023-2030.
The Cholesterol Screening market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Cholesterol Screening Report?

Have a Query? Click Here

Other Related Reports

Medical Sensors Comprehensive Study by Type (Biosensors, Temperature Sensors, Motion Sensors, Image Sensors, Flow Sensors, Pressure Sensors), Application (Diagnostics (HIV Test Strip Sensors, Blood G...
$ 3750
Intraoperative Neuromonitoring Comprehensive Study by Application (Neurosurgery, Spinal Surgery, Cardiovascular Surgery, ENT Surgery, Orthopedic Surgery, Other Surgeries), Product & Services (Systems...
$ 3750
Zirconium Dental Implants Comprehensive Study by Type (Cobalt Oxide, Cobalt Alloy, Others), Application (Hospitals, Dental Clinics, Others), Implant Type (Tapered Implants, Parallel-walled Implants),...
$ 3350
Ankle Replacement Comprehensive Study by Type (Multi-axis joint, Uniaxial joint), Application (Osteoarthritis, Rheumatoid Arthritis, Others), Design (HINTEGRA Total Ankle Replacement, Scandinavian To...
$ 3650
Drug Delivery Systems Comprehensive Study by Type (Oral Drug Delivery System, Injection-based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Trans ...
$ 3750
Topical Hair Loss Treatments Comprehensive Study by Type (Minoxidil Solution, Herbal Extract Treatment, Other), Application (Male, Female), Distribution Channel (Offline, Online) Players and Region -...
$ 3500